We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current THOXF market cap is 87.32M. The company's latest EPS is DKK -0.1484 and P/E is -1.55.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Total Revenue | 26.62M | 23.2M | 24.25M | 28.97M | 30.96M |
| Operating Income | -74.3M | -63.59M | -65.26M | -78.94M | -60.16M |
| Net Income | -69.64M | -61.56M | -57.11M | -75.92M | -56.33M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Total Assets | 42.68M | 140.29M | 81.26M | 108.64M | 89.81M |
| Total Liabilities | 17.36M | 39.37M | 35.29M | 38.42M | 29.65M |
| Total Equity | 25.32M | 100.91M | 45.96M | 70.22M | 60.16M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Operating | -60.16M | -35.62M | -64.58M | -52.49M | -55.46M |
| Investing | -2.06M | -1.52M | -412k | -503k | -277k |
| Financing | 33.61M | 127.04M | 1.1M | 88.7M | 40.79M |
| Market Cap | 87.32M |
| Price to Earnings Ratio | -1.55 |
| Price to Sales Ratio | 2.82 |
| Price to Cash Ratio | 1.32 |
| Price to Book Ratio | 1.45 |
| Dividend Yield | - |
| Shares Outstanding | 379.67M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 20k |
| 52 Week Change | 0.00% |
| 52 Week High | 0.434514 |
| 52 Week Low | 0.212 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Bioporto AS (CE) |
| Address |
tuborg havnevej 15 hellerup DK-2900 |
| Website | https://www.bioporto.com |
| Industry | biotechnology animal & plant (C36) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
